Dr Pelin Candarlioglu

Dr Pelin Candarlioglu is Founder and Director of 3D and 3Rs Ltd, an independent consultancy focused on the development, qualification and implementation of advanced human-relevant in vitro models for drug discovery and development. She has over two decades of experience in complex cell culture systems, organ-on-chip technologies and microphysiological systems, spanning academia, biotechnology and the pharmaceutical industry.
Prior to establishing her consultancy, Pelin held leadership positions at GSK, where she led Microphysiological Systems activities supporting drug discovery and safety assessment, Enplas, where she directed biology programmes in immuno-oncology and organ-on-chip development, and most recently Vivodyne, where she served as Director of Immunotherapy and led the development of advanced human immune system models.
She is currently Chair of the Industry Advisory Board of EUROoCS, an advisor to multiple international initiatives focused on model qualification and regulatory acceptance, and a frequent invited speaker at scientific, regulatory and industry forums. Her work centres on bridging the gap between innovative technologies and practical decision-making in pharmaceutical R&D, with particular expertise in Context of Use, model qualification, translational relevance and the integration of New Approach Methodologies (NAMs) into modern safety assessment strategies.